Role of T-cell anergy and suppression in susceptibility to IDDM

Research in Immunology

Volumn 148, Issue 5, 1997, Pages 348-358

  Bergerot, I ^a   Arreaza, G ^a   Cameron, M ^a,b   Chou, H ^a,b   Delovitch, T L ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; B LYMPHOCYTE; CLONAL ANERGY; DIAGNOSIS; DISEASE PREDISPOSITION; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030874898     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)87245-8     Document Type: Article

References (86)

1. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med., 182, 87-97.
2. Arreaza, G.A., Cameron, M.J. & Delovitch, T.L. (1996), Interleukin-4: Potential immunoregulatory agent in therapy of insulin-dependent diabetes mellitus. Clin. Immunother., 4, 251-260.
3. Arreaza, G.A., Cameron, M.J., Chakrabarti S. & Delovitch, T.L. (1997), CD28 costimulation prevents insulin dependent diabetes by an IL-4 dependent mechanism in NOD mice. J. Allergy Clin. Immunol., 99, S488.
4. Atkinson, M.A., MacLaren, N.K. & Luchetta, R. (1990), Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes, 39, 933-937.
5. Bachmaier, K., Pummerer, C., Shahinian, A., Ionescu, J., Neu, N., Mak, T. & Penninger, J.M. (1996), Induction of autoimmunity in the absence of CD28. J. Immunol., 157, 1752-1757.
6. Balasa, B. & Sarvetnick, N. (1996), The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J. Autoimmun., 9, 283-286.
7. Baxter, A.G., Adams, M.A. & Mandel, T.E. (1989), Comparison of high-and low-diabetes-incidence NOD mouse strains. Diabetes, 38, 1296-1300.
8. + T cells. J. Exp. Med., 166, 823-832.
9. + T cells that suppress adoptive transfer of diabetes. J. Autoimmun., 7, 655-663.
10. Bergerot, I, Ploix, C., Petersen, J., Moulin, V., Rask, C., Fabien, N., Lindblad, M., Mayer, A., Czerkinsky, C., Holmgren, J. & Thivolet, C. (1997a), A cholera toxoid-insulin conjugate as oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA (in press).
11. Bergerot, I., Chakrabarti, S. & Delovitch, T.L. (1997b), Oral insulin administration restores deficient T suppressor cell function in NOD mice, in "Tolerance and Autoimmunity" Keystone Symposium on Molecular and Cellular Biology (oral communication). Keystone, Colorado.
12. th Anniversary: Celebrating the Discovery of Insulin" (oral communication). Toronto, Canada.
13. Bluestone, J.A. (1995), New perspectives of CD28-B7-mediated T cell costimulation. Immunity, 2, 555-559.
14. L. Immunity, 3, 87-98.
15. Boitard, C., Yasunami, R., Dardenne, M. & Bach, J.F. (1989), T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med., 169, 1669-1680.
16. Boussiotis, V.A., Barber, D.L., Nakarai, T., Freeman, G.J., Gribben, J.G., Bernstein, G.M., D'Andrea, A.O., Ritz, J. & Nadler, L.M. (1994), Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science, 266, 1039-1042.
17. Bowman, M.A., Campbell, L., Darrow, B.L., Ellis, T.M., Suresh, A. & Atkinson, M.A. (1996), Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes, 45, 205-208.
18. Burtles, S.S., Trembleau, S., Drexler, K. & Hurtenbach, U. (1992), Absence of T cell tolerance to pancreatic islet cells. J. Immunol., 149, 2185-2193.
19. Cameron, M.J., Arreaza, G.A., Chakrabarti, S., Strieter, R.W. & Delovitch, T.L. (1997), Early IL-4 treatment prevents insulitis and IDDM in NOD mice via potentiation of Th2 cell function and modulation of lymphocyte migration, in "Tolerance and Autoimmunity" Keystone Symposium on Molecular and Cellular Biology (oral communication). Keystone, Colorado.
20. g7 molecules from nonobese diabetic mice are poor peptide binders. J. Immunol., 156, 450-458.
21. Charlton, B., Bacejl, A., Slattery, R.M. & Mandel, T.E. (1989), Cyclophosphamide induced diabetes in NOD/Wehi mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes, 38, 441-447.
22. Chatenoud, L., Thervet, E., Primo, J. & Bach, J.F. (1994), Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA, 91, 123-127.
23. Chatenoud, L., Primo, J. & Bach, J.F. (1997), CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol., 158, 2947-2954.
24. + T-cell line. Diabetologia, 36, 716-721.
25. + T cells from diabetic versus prediabetic NOD.NON-Thy-la donors. Diabetes, 42, 44-55.
26. Daniel, D., Gill, R.G., Schloot, N. & Wegmann, D. (1995), Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol., 25, 1056-1062.
27. Daniel, D. & Wegmann, D.R. (1996), Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA, 93, 956-960.
28. Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, P., Bedossa, P. & Bach, J.F. (1991), Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J. Autoimmun., 4, 237-248.
29. 67) prevents autoimmune diabetes in NOD mice. Diabetes, 43, 1494-1499.
30. Gerling, I.C., Serreze, D.V., Christianson, S.W. & Leiter, E.H. (1992), Intrathymic islet cell transplantation reduces β-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes, 41, 1672-1676.
31. Gerling, I.C., Atkinson, M.A. & Leiter, E.H. (1994), The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice. J. Autoimmun., 7, 851-858.
32. Glimcher, L.H., Steinberg, A.D., House S.B. & Green, I. (1980), The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J. Immunol., 125, 1832-1838.
33. + -like thymocytes in the NOD mouse. Eur. J. Immunol, 26, 2989-2998.
34. + T cell-defective IL-4 production in the nonobese diabetic mouse. Int. Immunol., 8, 1751-1758.
35. Hanson, M.S., Cetkovic-Cvrlje, M., Ramiya, V.K., Atkinson, M.A., MacLaren, N.K., Singh, B., Elliott, J.F., Serreze, D.V. & Leiter, E.H. (1996), Quantitative threshold of MHC class II I-E expressed on hematopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol., 157, 1279-1287.
36. Harrison, L.C., Dempsey-Collier, M., Kramer, D.R. & Takahashi, K. (1996), Aerosol insulin induces regulatory CDS γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med., 184, 2167-2174.
37. Haskins, K., Portas, M., Bergman, B., Lafferty, K. & Bradley, B. (1989), Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA, 86, 8000-8004.
38. Higuchi, Y., Herrera, P., Muniesa, P., Huarte, J., Belin, D., Ohashi, P., Aichele, P., Orci, L., Vassalli, J.D. & Vassalli, P. (1992), Expression of a tumor necrosis factor a transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med., 176, 1719-1731.
39. Hutchings, P.R. & Cooke A. (1990), The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun., 3, 175-185.
40. Jaramillo, A., Gill, B.M. & Delovitch T.L. (1994), Insulin-dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy? Life Sci., 55, 1163-77.
41. Kaufman, D.L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G.S.P., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J. & Lehmann, P.V. (1993), Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.), 366, 69-72.
42. Leiter, E.H., et al. (1997), in "Forum in Immunology". Res. Immunol., (this issue).
43. Lenschow, D.J., Herold, K.C., Rhee, L., Patel, B., Koons, A., Qin, H.Y., Fuchs, E., Singh, B., Thompson, C.B. & Bluestone, J.A. (1996), CD28/B7 regulation of Thl and Th2 subsets in the development of autoimmune diabetes. Immunity, 5, 285-293.
44. Lenschow, D.L., Huei-Ting Su, G., Zuckerman, L.A., Nabavi, N., Jellis, C.L., Gray, O.S., Miller, J. & Bluestone, J.A. (1993), Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA, 90, 11054-11058.
45. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today, 16, 34-38.
46. Maron, R., Hancock, W., Palanivel, V., Harn, D.A. & Weiner, H.L. (1995), Cell lines and cytokine patterns of NOD mice orally fed with insulin B chain and schistosome egg antigen, in "14th International Immunology and Diabetes Workshop" (oral communication). Orvieto, Italy.
47. Milich, D.R., Jones, J.E., McLachlan, A., Houghton, R., Thornton, G.B. & Hughes, J.L. (1989), Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants, influence of peptide-MHC interaction. J. Immunol., 143, 3148-56.
48. Muir, A., Peck, A., Clare-Salzler, M., Song, Y.H., Cornelius, J., Luchetta, R., Krischer, J. & MacLaren, N. (1995), Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest., 95, 628-634.
49. Mueller, R., Krahl, T. & Sarvetnick, N. (1996), Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 184, 1093-1099.
50. Noel, P.J., Boise, L.H., Green, J.M. & Thompson, C.B. (1996), CD28 costimulation prevents cell death during primary T cell activation. J. Immunol., 157, 636-642.
51. + T cell clone, I.S.2.15, has in vitro immunosuppressive properties. Eur. J. Immunol., 22, 2017-2023.
52. Pennline, K.J., Roque-Gaffney, E. & Monahan, M. (1994), Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol., 11, 169-175.
53. Petersen, J.S., Karlsen, A.E., Markholst, H., Worsaae, A., Dyrberg, T. & Michelsen, B. (1994), Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes, 43, 1478-1484.
54. Pilstrom, B., Bjork, L. & Bohme, J. (1995), Demonstration of a Th1 cytokine profile in the late phase of NOD insulitis. Cytokine, 7, 806-814.
55. Pleau, J.M., Fernandez-Saravia, F., Esling, A., Homo-Delarche, F. & Dardenne, M. (1995), Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clin. Immunol. Immunopathol., 76, 90-95.
56. Qin, H.Y., Sadelain, M.W.J., Hitchon, C., Lauzon, J. & Singh, B. (1993), Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol., 150, 2072-2080.
57. Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O., Bleackley, R.C. & Power, R.F. (1995), IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlate with autoimmune diabetes in nonobese diabetic mice. J. Immunol., 154, 4874-4882.
58. Rapoport, M.J., Jaramillo, A., Zipris, D., Lazarus, A.H., Serreze, D.V., Leiter, E.H., Cyopick, P., Danska, J.S. & Delovitch, T.L. (1993a), Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87-99.
59. ras activation. J. Exp. Med., 177, 1221-1226.
60. Sakaguchi, S., Toda, M., Asano, M., Itoh, M., Morse, S.S. & Sakaguchi, N. (1996), T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun., 9, 211-220.
61. Scott, B., Liblau, R., Degermann, S., Marconi, L.A., Ogata, L., Caton, A.J., McDevitt, H.O. & Lo, D. (1994), A role for non-MHC polymorphism in susceptibility to spontaneous autoimmunity. Immunity, 1, 73-83.
62. + regulatory T cells in the nonobese diabetic male mouse. Diabetologia, 37, 337-343.
63. Serreze, D.V. & Leiter, E.H. (1988), Defective activation of T suppressor cell function in nonobese diabetic mice. J. Immunol., 140, 3801-3807.
64. Serreze, D.V. (1993), Autoimmune diabetes results from genetic defects manifested by antigen presenting cells. FASEB J., 7, 1092-1096.
65. Serreze, D.V., Gaskins, H.R. & Leiter, E.H. (1993), Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol., 150, 2534-2543.
66. Serreze, D.V. & Leiter, E.H. (1988), Defective activation of T suppressor cell function in nonobese diabetic mice. J. Immunol., 140, 3801-3807.
67. Serreze, D.V. & Leiter, E.H. (1994), Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol., 6, 900-906.
68. + cells correlates with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes, 45, 71-78.
69. Sperling, A., Auger, J.A., Ehst, B.D., Rulifson, I.C., Thompson, C.B. & Bluestone, J.A. (1996), CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol., 157, 3909-3917.
70. Sun, J.B., Holmgren, J. & Czerkinsky, C. (1994), Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA, 891, 10795-10799.
71. + T cell clone that suppress autoimmune diabetes in nonobese diabetic mice. Int. Immunol., 8, 689-699.
72. Thivolet, C.H., Goulot, E., Bedossa, P., Durand, A., Bonnard, M. & Orgiazzi, J. (1991), Insulin prevents adoptive cell transfer of diabetes in the autoimmune nonobese diabetic mouse. Diabetologia, 34, 314-319.
73. Thompson, C.B. (1995), Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell, 81, 979-982.
74. Tian, J., Clare-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C, Atkinson, M., Mullen, Y., Sarvetnick, N., Tobin, A.J., Lehman, P.V. & Kaufman, D.L. (1996), Modulating autoimmune reponses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med., 2, 1348-1353.
75. Tisch, R., Yang, X.D., Singer, S.M., Liblau, R.S., Fugger, L. & McDevitt, H.O. (1993), Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature (Lond.), 366, 72-75.
76. Todd, J.A., Aitman, T.J., Cornall, R.J., Ghosh, S., Hall, J.R., Hearn, C.M., Knight, A.M., Love, J.M., McAleer, M.A., Prins, J.B. & al. (1991), Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (Lond.), 351, 542-547.
77. + T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production. Int. Immunol., 8, 1759-1766.
78. Von Herrath, M.G. & Oldstone, M.B.A. (1997), Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med., 185, 531-540.
79. Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E. & Hafler, D.A. (1994), Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol., 12, 809-837.
80. Wicker, L.S., Miller, B.J. & Mullen, Y. (1986), Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 35, 855-860.
81. Wogensen, L., Lee, M.S. & Sarvetnick, N. (1994), Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in non obese diabetic mice. J. Exp. Med., 179, 1379-1384.
82. Yu, L., Gianani, B. & Eisenbarth, G.S. (1994), Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type diabetes. Diabetes, 43, 1229-1233.
83. Zhang, Z.J., Davidson, L., Eisenbarth, G. & Weiner, H.L. (1991), Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA, 88, 10252-10256.
84. Zhang, Z.L., Constantinou, D., Mandel, T.E. & Georgiou, H.M. (1994), Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice. Autoimmunity, 17, 41-48.
85. Zipris, D., Crow, A.R. & Delovitch, T.L. (1991a), Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes, 40, 429-435.
86. Zipris, D., Lazarus, A.H., Crow, A.R., Hadzija, M. & Delovitch, T.L. (1991b), Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J. Immunol., 146, 3763-3771.